AYERST PLANNING ON FIRST QUARTER 1986 NDA SUBMISSION FOR ALREDASE (TOLRESTAT) IN DIABETIC NEUROPATHY; FIRM IS SHOOTING FOR EARLY 1987 MARKET LAUNCH